Exact Sciences Corp

EXAS

Company Profile

  • Business description

    Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

  • Contact

    5505 Endeavor Lane
    MadisonWI53719
    USA

    T: +1 608 284-5700

    E: [email protected]

    https://www.exactsciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    7,000

Stocks News & Analysis

etfs

ARK Innovation ETF has likely been a disappointment for most investors

Investors are fleeing for the exits amid the fund's underperformance this year.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,564.7047.00-0.55%
CAC 407,910.4931.93-0.40%
DAX 4024,122.4086.290.36%
Dow JONES (US)41,860.44816.80-1.91%
FTSE 1008,786.465.340.06%
HKSE23,695.88131.90-0.55%
NASDAQ18,872.64270.07-1.41%
Nikkei 22536,930.94368.04-0.99%
NZX 50 Index12,644.6458.46-0.46%
S&P 5005,844.6195.85-1.61%
S&P/ASX 2008,343.2043.60-0.52%
SSE Composite Index3,387.630.050.00%

Market Movers